Evidence map›Paper›PMID 42016791›Full record

ArticleCureus2026

Risk Factors Associated With Hospitalization, Severity, and Mortality From COVID-19 Among Children and Adolescents in Mexico.

Francisco Vargas Hernandez, Alexandra E Soto Piña, José J Garduño-García, Fernando Bastida Gonzalez, Alejandra D Benitez Arciniega, Luis R Garcia Cortes, Diana L Perez Cabrera, Samantha W Martínez Angeles, Caroline C Pulido-Alvarado, Elizabeth Alderete Flores

Abstract read
In one paragraph

Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Francisco Vargas HernandezFamily Medicine, Faculty of Medicine, Universidad Autonoma del Estado de Mexico, Toluca de Lerdo, MEX.
Alexandra E Soto PiñaDiabetes and Endocrinology, Faculty of Medicine, Universidad Autonoma del Estado de Mexico, Toluca de Lerdo, MEX.
José J Garduño-GarcíaDiabetes and Endocrinology, Faculty of Medicine, Universidad Autónoma del Estado de México, Toluca de Lerdo, MEX.
Fernando Bastida GonzalezAllergy and Immunology, Laboratorio de Biologia Molecular Estatal, Instituto de Salud del Estado de Mexico, Toluca de Lerdo, MEX.
Alejandra D Benitez ArciniegaDiabetes and Endocrinology, Faculty of Medicine, Universidad Autonoma del Estado de Mexico, Toluca de Lerdo, MEX.
Luis R Garcia CortesFamily Medicine, Coordinación Auxiliar Médica de Investigación en Salud, OOAD México Oriente, Instituto Mexicano del Seguro Social, Tlalnepantla de Baz, MEX.
Diana L Perez CabreraGeneral Practice, Unidad de Medicina Familiar No. 64 "Tequesquinahuac", Instituto Mexicano del Seguro Social, Tlalnepantla de Baz, MEX.
Samantha W Martínez AngelesGeneral Practice, Unidad de Medicina Familiar No. 64 "Tequesquinahuac", Instituto Mexicano del Seguro Social, Tlalnepantla de Baz, MEX.
Caroline C Pulido-AlvaradoPediatrics, Faculty of Medicine, Universidad Autonoma del Estado de Mexico, Toluca de Lerdo, MEX.
Elizabeth Alderete FloresGeneral Practice, Unidad de Medicina Familiar No. 64 "Tequesquinahuac", Instituto Mexicano del Seguro Social, Tlalnepantla de Baz, MEX.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction Mexico has seen a high number of COVID-19 cases and deaths among children. The majority of cases were in Mexico City and the State of Mexico. There is heterogeneity in the clinical and epidemiological parameters of risk or protection at the national and international levels in this age group. The objective of the study is to identify the epidemiological and clinical factors associated with severe COVID-19, hospitalization, pneumonia at admission, and mortality among children and adolescents. Materials and methods A retrospective, analytical, and multicenter study based on hospital patients was conducted between 2020 and 2023 in four general and regional hospitals of the Mexican Social Security Institute (IMSS), Mexico. A total of 1,698 subjects diagnosed with COVID-19, aged between one and 17 years of both sexes, were included. Multiple binary logistic regressions were performed and stratified by laboratory diagnosis, obtaining simple and adjusted ORs for the clinical and epidemiological variables associated with severe COVID-19. Results The model adjusted and stratified by laboratory diagnosis for COVID-19 severity showed that obesity had an OR of 2.46 (95% CI, 1.37-4.43), being under five years of age had an OR of 2.01 (95% CI, 1.43-2.84), headache had an OR of 2.00 (95% CI, 1.18-3.39) and dyspnea had an OR of 1.82 (95% CI, 1.06-3.11). In the unadjusted analysis, male sex was associated with an OR of 1.82 (95% CI, 1.4-2.2) for severity. Conclusion The results suggest that being under five years of age, being overweight or obese, and experiencing cough, headache, and dyspnea are risk factors for COVID-19 complications in the hospital setting, based on clinical diagnosis. These findings have very limited applicability to mild community-acquired cases. Prospective cohort studies are needed to confirm these findings and include pediatric anthropometric standards.

Indexed as

children and adolescentscovid-19covid-19 diseasecovid-19 severityhospitalizationoutcomes in hospitalized covid-19 patients

Identifiers

PMID42016791
PMCPMC13095144

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.